PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 400 shares, a decrease of 97.2% from the November 15th total of 14,500 shares. Based on an average daily volume of 46,900 shares, the days-to-cover ratio is currently 0.0 days.

PURE Bioscience Price Performance

Shares of PURE stock traded up $0.01 during trading hours on Friday, reaching $0.07. 52,615 shares of the stock were exchanged, compared to its average volume of 29,677. The firm has a market capitalization of $7.83 million, a P/E ratio of -1.75 and a beta of 0.01. The business’s fifty day moving average is $0.09 and its two-hundred day moving average is $0.08. PURE Bioscience has a 12-month low of $0.06 and a 12-month high of $0.16.

PURE Bioscience (OTCMKTS:PURE) last posted its quarterly earnings results on Tuesday, October 29th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.47 million during the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.